- Home
- SST vs MDCX Comparison
SST vs MDCX Comparison
Compare SST & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SST | MDCX |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United States |
| Employees | 250 | 12 |
| Industry | Diversified Commercial Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9M | 13.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SST | MDCX |
|---|---|---|
| Price | $3.69 | $0.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $10.00 | ★ $23.50 |
| AVG Volume (30 Days) | 6.3M | ★ 7.4M |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.29 | $0.37 |
| 52 Week High | $11.30 | $8.90 |
Technical Indicators
Market Signals| Indicator | SST | MDCX |
|---|---|---|
| Relative Strength Index (RSI) | 57.97 | 38.29 |
| Support Level | $3.55 | $0.37 |
| Resistance Level | $4.54 | $1.70 |
| Average True Range (ATR) | 1.00 | 0.05 |
| MACD | 0.29 | 0.03 |
| Stochastic Oscillator | 56.18 | 62.93 |
Price Performance
Historical ComparisonAbout SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It operate several flagship brands across multiple consumer verticals, including shopping, travel and search, and a customer acquisition and marketing platform powered by Artificial Intelligence and machine learning. The company's segment includes Marketing and Products. It generates maximum revenue from the Marketing segment. Geographically, it operates in United States and Other countries.
About MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.